Clinical Study

Characterization of Acute Lymphoblastic Leukemia Subtypes in Moroccan Children

Table 1

Panel of Monoclonal Antibodies used in this study for immunophenotypic acute leukemia characterization.

B-cell markersT-cell markers Myeloid markersNo specific markers

First stepCD79a, CD19, CD22sCD3, cyCD3, CD7CD13, CD33, anti-MPOCD45
Second stepcytIg, sIgCD1a, CD4, CD5, CD8 CD117, CD41, CD61, GlycoACD34, DR, TdT, CD10

sIg: surface immunoglobulin, cyIg: cytoplasmic immunoglobulin, sCD3: surface CD3, cyCD3: cytoplasmic CD3, MPO: myeloperoxidase, Glyco A: Glycophorin A, DR: HLA-DR: antigen, TdT: terminal deoxynucleotidyl transferase.